{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:24:51Z","timestamp":1792113891575,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00428-023-03720-5","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T16:02:46Z","timestamp":1703001766000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Shedding light on PRAME expression in dysplastic nevi: a cohort study"],"prefix":"10.1007","volume":"485","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-6951","authenticated-orcid":false,"given":"Lorenzo","family":"Innocenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-3827","authenticated-orcid":false,"given":"Rosa","family":"Scarpitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2601-3625","authenticated-orcid":false,"given":"Serena","family":"Corraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2570-0295","authenticated-orcid":false,"given":"Valerio","family":"Ortenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-3222","authenticated-orcid":false,"given":"Angelo G.","family":"Bonadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3629-8502","authenticated-orcid":false,"given":"Barbara","family":"Loggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"De Ieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8195-9445","authenticated-orcid":false,"given":"Antonio G.","family":"Naccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-7980","authenticated-orcid":false,"given":"Giuseppe N.","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-0845","authenticated-orcid":false,"given":"Cristian","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"3720_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2022.04.068","volume":"88","author":"R Drozdowski","year":"2023","unstructured":"Drozdowski R, Spaccarelli N, Peters MS, Grant-Kels JM (2023) Dysplastic nevus part I: historical perspective, classification, and epidemiology. J Am Acad Dermatol 88:1\u201310. https:\/\/doi.org\/10.1016\/j.jaad.2022.04.068","journal-title":"J Am Acad Dermatol"},{"key":"3720_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2559.2009.03450.x","volume":"56","author":"DE Elder","year":"2010","unstructured":"Elder DE (2010) Dysplastic naevi: an update. Histopathology 56:112\u2013120. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03450.x","journal-title":"Histopathology"},{"key":"3720_CR3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1365-2133.2006.07466.x","volume":"155","author":"AR Shors","year":"2006","unstructured":"Shors AR, Kim S, White E et al (2006) Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma: dysplastic naevi and melanoma. Br J Dermatol 155:988\u2013993. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07466.x","journal-title":"Br J Dermatol"},{"key":"3720_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","volume":"144","author":"DE Elder","year":"2020","unstructured":"Elder DE, Bastian BC, Cree IA et al (2020) The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med 144:500\u2013522. https:\/\/doi.org\/10.5858\/arpa.2019-0561-RA","journal-title":"Arch Pathol Lab Med"},{"key":"3720_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/cup.14165","volume":"49","author":"O Aydin Ulgen","year":"2022","unstructured":"Aydin Ulgen O, Y\u0131ld\u0131z P, Acar HC, Demirkesen C (2022) Analysis of interobserver reproducibility in grading dysplastic nevi: results of the application of the 2018 World Health Organization grading criteria. J Cutan Pathol 49:343\u2013349. https:\/\/doi.org\/10.1111\/cup.14165","journal-title":"J Cutan Pathol"},{"key":"3720_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1590\/S0365-05962013000100002","volume":"88","author":"AB Nobre","year":"2013","unstructured":"Nobre AB, Pi\u00f1eiro-Maceira J, Raggio Luiz R (2013) Analysis of interobserver reproducibility in grading histological patterns of dysplastic nevi*. An Bras Dermatol 88:23\u201331. https:\/\/doi.org\/10.1590\/S0365-05962013000100002","journal-title":"An Bras Dermatol"},{"key":"3720_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","volume":"6","author":"H Ikeda","year":"1997","unstructured":"Ikeda H, Leth\u00e9 B, Lehmann F et al (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199\u2013208. https:\/\/doi.org\/10.1016\/S1074-7613(00)80426-4","journal-title":"Immunity"},{"key":"3720_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1476-4598-9-226","volume":"9","author":"F Wadelin","year":"2010","unstructured":"Wadelin F, Fulton J, McEwan PA et al (2010) Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia. Mol Cancer 9:226. https:\/\/doi.org\/10.1186\/1476-4598-9-226","journal-title":"Mol Cancer"},{"key":"3720_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.tranon.2018.01.011","volume":"11","author":"Z Liu","year":"2018","unstructured":"Liu Z, Li M, Jiang Z, Wang X (2018) A comprehensive immunologic portrait of triple-negative breast cancer. Transl Oncol 11:311\u2013329. https:\/\/doi.org\/10.1016\/j.tranon.2018.01.011","journal-title":"Transl Oncol"},{"key":"3720_CR10","doi-asserted-by":"publisher","unstructured":"Xu Y, Zou R, Wang J et al (2020) The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer. Cell Prolif 53. https:\/\/doi.org\/10.1111\/cpr.12770","DOI":"10.1111\/cpr.12770"},{"key":"3720_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03629-z","author":"A \u0160afanda","year":"2023","unstructured":"\u0160afanda A, Kendall B\u00e1rt\u016f M, Mich\u00e1lkov\u00e1 R et al (2023) Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-023-03629-z","journal-title":"Virchows Arch"},{"key":"3720_CR12","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3390\/cancers15092415","volume":"15","author":"V Hedrich","year":"2023","unstructured":"Hedrich V, Breitenecker K, Ortmayr G et al (2023) PRAME is a novel target of tumor-intrinsic Gas6\/Axl activation and promotes cancer cell invasion in hepatocellular carcinoma. Cancers 15:2415. https:\/\/doi.org\/10.3390\/cancers15092415","journal-title":"Cancers"},{"key":"3720_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/biolre\/ioab074","volume":"105","author":"CH Kern","year":"2021","unstructured":"Kern CH, Yang M, Liu W-S (2021) The PRAME family of cancer testis antigens is essential for germline development and gametogenesis. Biol Reprod 105:290\u2013304. https:\/\/doi.org\/10.1093\/biolre\/ioab074","journal-title":"Biol Reprod"},{"key":"3720_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/gcc.20465","volume":"46","author":"T Schenk","year":"2007","unstructured":"Schenk T, Stengel S, Goellner S et al (2007) Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies. Genes Chromosomes Cancer 46:796\u2013804. https:\/\/doi.org\/10.1002\/gcc.20465","journal-title":"Genes Chromosomes Cancer"},{"key":"3720_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","volume":"122","author":"MT Epping","year":"2005","unstructured":"Epping MT, Wang L, Edel MJ et al (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122:835\u2013847. https:\/\/doi.org\/10.1016\/j.cell.2005.07.003","journal-title":"Cell"},{"key":"3720_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/bjc.2016.217","volume":"115","author":"N Neuhaus","year":"2016","unstructured":"Neuhaus N (2016) PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers. Br J Cancer 115:401\u2013402. https:\/\/doi.org\/10.1038\/bjc.2016.217","journal-title":"Br J Cancer"},{"key":"3720_CR17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/cup.14000","volume":"48","author":"AK Alomari","year":"2021","unstructured":"Alomari AK, Tharp AW, Umphress B, Kowal RP (2021) The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors. J Cutan Pathol 48:1115\u20131123. https:\/\/doi.org\/10.1111\/cup.14000","journal-title":"J Cutan Pathol"},{"key":"3720_CR18","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","volume":"42","author":"C Lezcano","year":"2018","unstructured":"Lezcano C, Jungbluth AA, Nehal KS et al (2018) PRAME expression in melanocytic tumors. Am J Surg Pathol 42:1456\u20131465. https:\/\/doi.org\/10.1097\/PAS.0000000000001134","journal-title":"Am J Surg Pathol"},{"key":"3720_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/cup.13818","volume":"47","author":"SS Raghavan","year":"2020","unstructured":"Raghavan SS, Wang JY, Kwok S et al (2020) PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features. J Cutan Pathol 47:1123\u20131131. https:\/\/doi.org\/10.1111\/cup.13818","journal-title":"J Cutan Pathol"},{"key":"3720_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2021.12.008","volume":"121","author":"A Fattori","year":"2022","unstructured":"Fattori A, de la Fouchardi\u00e8re A, Cribier B, Mitcov M (2022) Preferentially expressed antigen in melanoma immunohistochemistry as an adjunct for evaluating ambiguous melanocytic proliferation. Hum Pathol 121:19\u201328. https:\/\/doi.org\/10.1016\/j.humpath.2021.12.008","journal-title":"Hum Pathol"},{"key":"3720_CR21","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.3390\/diagnostics12092197","volume":"12","author":"G Cazzato","year":"2022","unstructured":"Cazzato G, Cascardi E, Colagrande A et al (2022) PRAME immunoexpression in 275 cutaneous melanocytic lesions: a double institutional experience. Diagnostics 12:2197. https:\/\/doi.org\/10.3390\/diagnostics12092197","journal-title":"Diagnostics"},{"key":"3720_CR22","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.3390\/ijms23115911","volume":"23","author":"C Ricci","year":"2022","unstructured":"Ricci C, Dika E, Ambrosi F et al (2022) Cutaneous melanomas: a single center experience on the usage of immunohistochemistry applied for the diagnosis. Int J Mol Sci 23:5911. https:\/\/doi.org\/10.3390\/ijms23115911","journal-title":"Int J Mol Sci"},{"key":"3720_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/cup.13958","volume":"48","author":"ME Lohman","year":"2021","unstructured":"Lohman ME, Steen AJ, Grekin RC, North JP (2021) The utility of PRAME staining in identifying malignant transformation of melanocytic nevi. J Cutan Pathol 48:856\u2013862. https:\/\/doi.org\/10.1111\/cup.13958","journal-title":"J Cutan Pathol"},{"key":"3720_CR24","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/his.14312","volume":"78","author":"SE Gradecki","year":"2021","unstructured":"Gradecki SE, Valdes-Rodriguez R, Wick MR, Gru AA (2021) PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna. Histopathology 78:1000\u20131008. https:\/\/doi.org\/10.1111\/his.14312","journal-title":"Histopathology"},{"key":"3720_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/PAS.0000000000001393","volume":"44","author":"C Lezcano","year":"2020","unstructured":"Lezcano C, Pulitzer M, Moy AP et al (2020) Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma. Am J Surg Pathol 44:503\u2013508. https:\/\/doi.org\/10.1097\/PAS.0000000000001393","journal-title":"Am J Surg Pathol"},{"key":"3720_CR26","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.3390\/ijms24076388","volume":"24","author":"EAT Koch","year":"2023","unstructured":"Koch EAT, Erdmann M, Berking C et al (2023) Standardized computer-assisted analysis of prame immunoreactivity in dysplastic nevi and superficial spreading melanomas. Int J Mol Sci 24:6388. https:\/\/doi.org\/10.3390\/ijms24076388","journal-title":"Int J Mol Sci"},{"key":"3720_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1159\/000487353","volume":"45","author":"H Zhu","year":"2018","unstructured":"Zhu H, Wang J, Yin J et al (2018) Downregulation of PRAME suppresses proliferation and promotes apoptosis in hepatocellular carcinoma through the activation of p53 mediated pathway. Cell Physiol Biochem 45:1121\u20131135. https:\/\/doi.org\/10.1159\/000487353","journal-title":"Cell Physiol Biochem"},{"key":"3720_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055897","volume":"8","author":"S Kewitz","year":"2013","unstructured":"Kewitz S, Staege MS (2013) Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells. PLoS ONE 8:e55897. https:\/\/doi.org\/10.1371\/journal.pone.0055897","journal-title":"PLoS ONE"},{"key":"3720_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/cancers14010003","volume":"14","author":"ES Borden","year":"2021","unstructured":"Borden ES, Adams AC, Buetow KH et al (2021) Shared gene expression and immune pathway changes associated with progression from nevi to melanoma. Cancers 14:3. https:\/\/doi.org\/10.3390\/cancers14010003","journal-title":"Cancers"},{"key":"3720_CR30","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.3390\/cancers13153864","volume":"13","author":"M Gassenmaier","year":"2021","unstructured":"Gassenmaier M, Hahn M, Metzler G et al (2021) Diffuse PRAME expression is highly specific for thin melanomas in the distinction from severely dysplastic nevi but does not distinguish metastasizing from non-metastasizing thin melanomas. Cancers 13:3864. https:\/\/doi.org\/10.3390\/cancers13153864","journal-title":"Cancers"},{"key":"3720_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/PAS.0000000000001492","volume":"44","author":"C Lezcano","year":"2020","unstructured":"Lezcano C, Jungbluth AA, Busam KJ (2020) Comparison of immunohistochemistry for PRAME with cytogenetic test results in the evaluation of challenging melanocytic tumors. Am J Surg Pathol 44:893\u2013900. https:\/\/doi.org\/10.1097\/PAS.0000000000001492","journal-title":"Am J Surg Pathol"},{"key":"3720_CR32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/cup.14470","volume":"50","author":"K Goto","year":"2023","unstructured":"Goto K, Yoshikawa S, Takai T et al (2023) Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: a study of 16 cases. J Cutan Pathol 50:739\u2013747. https:\/\/doi.org\/10.1111\/cup.14470","journal-title":"J Cutan Pathol"},{"key":"3720_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.30699\/ijp.2020.130968.2451","volume":"16","author":"M Nasimi","year":"2021","unstructured":"Nasimi M, Ghanadan A, Kamyab K et al (2021) Prevalence and main determinants of BRAF V600E mutation in dysplastic and congenital nevi. Iran J Pathol 16:51\u201356. https:\/\/doi.org\/10.30699\/ijp.2020.130968.2451","journal-title":"Iran J Pathol"},{"key":"3720_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jaad.2018.03.052","volume":"79","author":"M Kiuru","year":"2018","unstructured":"Kiuru M, Tartar DM, Qi L et al (2018) Improving classification of melanocytic nevi: association of BRAF V600E expression with distinct histomorphologic features. J Am Acad Dermatol 79:221\u2013229. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.052","journal-title":"J Am Acad Dermatol"},{"key":"3720_CR35","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.jid.2021.11.025","volume":"142","author":"ME Muse","year":"2022","unstructured":"Muse ME, Bergman DT, Salas LA et al (2022) Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi. J Invest Dermatol 142:1893-1902.e7. https:\/\/doi.org\/10.1016\/j.jid.2021.11.025","journal-title":"J Invest Dermatol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03720-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T07:05:14Z","timestamp":1721372714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03720-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3720"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03720-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"7 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (Comitato Etico area Vasta Nord Ovest Toscana, Prot. n:15\/120. Approval date: 09\/03\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent has been obtained from the patient(s) to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}